Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : UPCA - Uniprime Capital Acceptance, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Patrick Lauder who wrote (50)	6/23/1999 8:10:00 AM
From: Patrick Lauder	Read Replies (1) \| Respond to of 640

I have been super busy last few days, so I will post some highlights of fax that company sent me about Mr. Flores work. - His work was carried out with a team of sixteen with backgrounds predominantly in the field of chemistry, along with the assistance of three distinguished professors from the UIniversity of Spain: Dr. Moya, Professor Fuentes and Professor Castro. -The discovery of the effects of The Plasma Plus on HIV actually too place on November 8, 1994 when the introduction of the Plasma Plus Formula led to the discovery that the bone marrow of one of the patients was producing up to 3X the amount of red blood cells per cm3 of the average person that translated into more oxygen into the blood. It was also therefore producing higher white cell count per cm3 for fighting infection...... Additional testing on HIV and AIDS patients from that point on further validated the ability of the Plasma Plus to reverse the effects of the HIV and AIDS stages and return the patient to normal CD4+ T-cell levels. - case study: On March 4, 1977 the patient's weight was 122 lbs. He was standing on his own for up to 7 minutes at a time. His blood profiles were still showing the virus, but the effects were lessened and the virus is not as prevalent. Scans revealed the presence of scar tissue on the liver. Treatment continued with titration of the dosage to wean the patient's body from the Plasma Plus. This weaning allows the body to gradually regenerate and begin to rebuild the system defenses. The weaning period continued through the rest of March and April, The dosages were decreased by one and one half hours per week, approximately. Update: June 15, 1998 the patient was treated then examined by two medical doctors from the University Hospital of Madrid and myself. The blood profiles revealed lever and kidney functions were within normal limits. Scans revealed the liver had regenerated and there existed only areas of discoloration. These areas were biopsied and found to contain normal liver tissue. No virus could be isolated in the blood. CNS examination was better than expected. The patient's weight was up to 178lbs. His skin color was good. The patient was appropriate in his response. Next follow up of this patient will be June 6, 1999. I will post more tomorrow!!! Pat